Suggested Topics within your search.
Suggested Topics within your search.
- Pharmacology 15
- Drug Therapy 4
- Nursing 4
- Pharmaceutical Preparations 4
- pharmacology 4
- Anesthetics 3
- Anesthesia 2
- Examinations 2
- Licenses 2
- Pharmacological Phenomena 2
- Physicians 2
- administration & dosage 2
- methods 2
- Anesthesiology 1
- Chemotherapy 1
- Drug therapy 1
- Drugs 1
- Handbooks, manuals, etc 1
- Intraoperative Complications 1
- MEDICAL / Pharmacology 1
- MEDICAL / Test Preparation & Review 1
- Mnemonics 1
- Nursing Care 1
- Physiological effect 1
- Rick Factors 1
- Safety Management 1
- Therapeutic use 1
- Therapeutics 1
- Vitamin E 1
- chemistry 1
-
2141
Call for Papers - Advancing Astropharmacy and Sports Pharmacy
Published 2025-02-01“…., (shireenaziz1994@yahoo.com) Shireen Aziz, Pharm.D., MS Pharmacology, is a Ph.D. student in Clinical Pharmacy actively contributing to the I-CARE4OLD project. …”
Get full text
Article -
2142
Is Parkinson’s Disease Truly a Prion-Like Disorder? An Appraisal of Current Evidence
Published 2015-01-01Get full text
Article -
2143
Importance of Modulating Kynurenic Acid Metabolism—Approaches for the Treatment of Dementia
Published 2025-01-01“…The newly developed <i>Helix pomatia</i> snail model of memory can be used for the assessment of novel pharmacological approaches. Dietary supplementation with natural molecular/herbal extracts, exercise, and physical activity have significant impacts on endogenous pharmacology by reducing kynurenic acid synthesis, and these factors are likely to significantly modulate steady-state biological conditions and delay the negative consequences of aging, including the onset of pathological processes.…”
Get full text
Article -
2144
-
2145
-
2146
Pancreatic Cancer: What the Oncologist Can Offer for Palliation
Published 2002-01-01Get full text
Article -
2147
Genetic Variants in SNCA and the Risk of Sporadic Parkinson’s Disease and Clinical Outcomes: A Review
Published 2017-01-01Get full text
Article -
2148
-
2149
PPAR Gamma Activators: Off-Target Against Glioma Cell Migration and Brain Invasion
Published 2008-01-01Get full text
Article -
2150
-
2151
Advances and Challenges in Cancer Stem Cells for Onco-Therapeutics
Published 2023-01-01Get full text
Article -
2152
Co-Amoxiclav Induced Immune Haemolytic Anaemia: A Case Report
Published 2020-01-01Get full text
Article -
2153
Presenting a New Standard Drug Model for Turmeric and Its Prized Extract, Curcumin
Published 2018-01-01“…Despite the expansive reports of curcucmin’s therapeutic value, clinical reliability and research repeatability with curcumin treatment are still poor. The pharmacology must be better understood and reliably mapped if curcumin is to be accepted and used in modern medical applications. …”
Get full text
Article -
2154
Therapy of Inflammatory Bowel Disease using New 5-ASA Compounds: An Introduction
Published 1989-01-01Get full text
Article -
2155
Resurgence of Polymyxin B for MDR/XDR Gram-Negative Infections: An Overview of Current Evidence
Published 2017-01-01“…Here, we present a literature review of polymyxin B in Gram-negative infections with update on its pharmacology.…”
Get full text
Article -
2156
miR-214-3p Deficiency Enhances Caspase-1-Dependent Pyroptosis of Microglia in White Matter Injury
Published 2022-01-01“…Here, we report that the caspase-1 inflammasome is abundantly activated in the microglia of WMI mice and results in increased pyroptosis of microglia. Pharmacology inhibition of caspase-1 cleavage alleviated the pathogenesis of WMI mice. …”
Get full text
Article -
2157
MicroRNAs in Human Pituitary Adenomas
Published 2014-01-01“…Deregulated miRNAs and their targets contribute to pituitary adenomas progression and are associated with cell cycle control, apoptosis, invasion, and pharmacological treatment of pituitary adenomas. To provide an overview of miRNAs dysregulation and functions of these miRNAs in pituitary adenoma progression, we summarize the deregulated miRNAs and their targets to shed more light on their potential as therapeutic targets and novel biomarkers.…”
Get full text
Article -
2158
Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose Tissue
Published 2018-01-01“…Whether solutions to these issues will be found in further adjustments and combinations between drugs already in use or necessarily in new advances in pharmacology is not known. To better understand the effect of drugs used in dyslipidemia and obesity on adipose tissue not only is challenging for physicians but could also be the next step to tackle cardiovascular disease.…”
Get full text
Article -
2159
-
2160
An Audit of Pain Management Following Pediatric Day Surgery at British Columbia Children’s Hospital
Published 2012-01-01Get full text
Article